DAVID W JANEWAY

Allopathic & Osteopathic Physicians|Family Medicine ARLINGTON, WA NPI 1821177437

General Payments — all program years on this page

$4,060.99

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 209
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $467.24 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $467.2421

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $745.6042
2019 $666.1634
2020 $318.7318
2021 $574.5230
2022 $740.4939
2023 $548.2525
2024 $467.2421

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087108222 Novartis Pharmaceuticals Corporation $17.85 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096649761 Novo Nordisk Inc $21.23 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103987008 ABBVIE INC. $29.16 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104490510 AstraZeneca Pharmaceuticals LP $16.06 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104567418 AstraZeneca Pharmaceuticals LP $14.82 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104666083 AstraZeneca Pharmaceuticals LP $22.70 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104668463 AstraZeneca Pharmaceuticals LP $14.82 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105697790 AstraZeneca Pharmaceuticals LP $15.75 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111608419 Amgen Inc. $33.64 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116499523 GlaxoSmithKline, LLC. $20.32 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118168122 Boehringer Ingelheim Pharmaceuticals, Inc. $23.60 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118914837 Otsuka America Pharmaceutical, Inc. $26.90 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125289530 Abbott Laboratories $23.16 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132076575 PFIZER INC. $24.71 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136135035 Lilly USA, LLC $28.52 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136136112 Lilly USA, LLC $24.30 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138837328 Edwards Lifesciences Corporation $25.85 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138837374 Edwards Lifesciences Corporation $21.27 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144591888 Xeris Pharmaceuticals, Inc. $15.34 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145644134 Neurelis, Inc. $19.50 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148868837 Sumitomo Pharma America, Inc. $27.74 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.